Comparison

TAK-901 European Partner

Item no. TMO-T2709-500mg
Manufacturer TargetMol
CASRN 934541-31-8
Amount 500 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mL x 10 mM (in DMSO) 1 mg 25 mg 2 mg 500 mg 50 mg 5 mg
Category
Type Chemicals
Specific against other
Formula C28H32N4O3S
Smiles CCS(=O)(=O)c1cccc(c1)-c1cc(C(=O)NC2CCN(C)CC2)c(C)c2[nH]c3ncc(C)cc3c12
ECLASS 10.1 32160000
ECLASS 11.0 32160000
UNSPSC 12000000
Alias TAK901
Shipping Condition Cool pack
Available
Manufacturer - Targets
Src|||JAK|||Aurora Kinase|||CDK
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
504.64
Description
TAK-901 has been used in trials studying the treatment of Lymphoma, Myelofibrosis, Multiple Myeloma, Myeloid Metaplasia, and Advanced Solid Tumors, among others.
Pathways
JAK/STAT signaling|||Tyrosine Kinase/Adaptors|||Chromatin/Epigenetic|||Cell Cycle/Checkpoint|||Angiogenesis|||Stem Cells
Bioactivity
TAK-901 has been used in trials studying the treatment of Lymphoma, Myelofibrosis, Multiple Myeloma, Myeloid Metaplasia, and Advanced Solid Tumors, among others.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 500 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close